These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25165975)

  • 1. The calcineurin inhibitor tacrolimus reduces proteinuria in membranous nephropathy accompanied by a decrease in angiopoietin-like-4.
    Peng L; Ma J; Cui R; Chen X; Wei SY; Wei QJ; Li B
    PLoS One; 2014; 9(8):e106164. PubMed ID: 25165975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin inhibitors ameliorate PAN-induced podocyte injury through the NFAT-Angptl4 pathway.
    Shen X; Zhang Y; Lin C; Weng C; Wang Y; Feng S; Wang C; Shao X; Lin W; Li B; Wang H; Chen J; Jiang H
    J Pathol; 2020 Nov; 252(3):227-238. PubMed ID: 32686149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiopoietin-Like-4, a Potential Target of Tacrolimus, Predicts Earlier Podocyte Injury in Minimal Change Disease.
    Li JS; Chen X; Peng L; Wei SY; Zhao SL; Diao TT; He YX; Liu F; Wei QJ; Zhang QF; Li B
    PLoS One; 2015; 10(9):e0137049. PubMed ID: 26352670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro.
    Chen ZH; Qin WS; Zeng CH; Zheng CX; Hong YM; Lu YZ; Li LS; Liu ZH
    Kidney Int; 2010 Jun; 77(11):974-88. PubMed ID: 20375980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome.
    Clement LC; Avila-Casado C; Macé C; Soria E; Bakker WW; Kersten S; Chugh SS
    Nat Med; 2011 Jan; 17(1):117-22. PubMed ID: 21151138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of podocyte-secreted angiopoietin-like-4 in diabetic nephropathy.
    Ma J; Chen X; Li JS; Peng L; Wei SY; Zhao SL; Li T; Zhu D; He YX; Wei QJ; Li B
    Endocrine; 2015 Jun; 49(2):373-84. PubMed ID: 25424436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragaloside IV relieves passive heymann nephritis and podocyte injury by suppressing the TRAF6/NF-κb axis.
    Ma Y; Hu Y; Ruan Y; Jiang X; Zhao M; Wang Y; Ke Y; Shi M; Lu G
    Ren Fail; 2024 Dec; 46(2):2371992. PubMed ID: 39082739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhodojaponin VI ameliorates podocyte injury related with MDM2/Notch1 pathway in rat experimental membranous nephropathy.
    Song A; Yan R; Qiu Y; Yin X; Xiong J; Yao G; Zhang C
    Nephrology (Carlton); 2024 Sep; 29(9):555-564. PubMed ID: 39011853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction (MFSD) to repair podocyte damage.
    Zhao Q; Dai H; Jiang H; Zhang N; Hou F; Zheng Y; Gao Y; Liu W; Feng Z; Hu Y; Tang X; Rui H; Liu B
    Biomed Pharmacother; 2024 May; 174():116583. PubMed ID: 38626520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy.
    Floege J; Kriz W; Schulze M; Susani M; Kerjaschki D; Mooney A; Couser WG; Koch KM
    J Clin Invest; 1995 Dec; 96(6):2809-19. PubMed ID: 8675651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.
    Shen X; Jiang H; Ying M; Xie Z; Li X; Wang H; Zhao J; Lin C; Wang Y; Feng S; Shen J; Weng C; Lin W; Wang H; Zhou Q; Bi Y; Li M; Wang L; Zhu T; Huang X; Lan HY; Zhou J; Chen J
    Sci Rep; 2016 Sep; 6():32087. PubMed ID: 27580845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoids augment the expression of podocyte proteins by glomerular parietal epithelial cells in experimental glomerular disease.
    Zhang J; Pippin JW; Vaughan MR; Krofft RD; Taniguchi Y; Romagnani P; Nelson PJ; Liu ZH; Shankland SJ
    Nephron Exp Nephrol; 2012; 121(1-2):e23-37. PubMed ID: 23107969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy.
    Fujino T; Hasebe N
    BMC Nephrol; 2016 Nov; 17(1):179. PubMed ID: 27855638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy.
    Zhang Q; Shi SF; Zhu L; Lv JC; Liu LJ; Chen YQ; Zhang H; Wang HY
    Am J Nephrol; 2012; 35(4):312-20. PubMed ID: 22456060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of calcineurin (CN) in kidney glomerular podocyte: CN inhibitor ameliorated proteinuria by inhibiting the redistribution of CN at the slit diaphragm.
    Wakamatsu A; Fukusumi Y; Hasegawa E; Tomita M; Watanabe T; Narita I; Kawachi H
    Physiol Rep; 2016 Mar; 4(6):. PubMed ID: 27009276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Klotho Stabilizes the Podocyte Actin Cytoskeleton in Idiopathic Membranous Nephropathy through Regulating the TRPC6/CatL Pathway.
    Wang H; Liu H; Cheng H; Xue X; Ge Y; Wang X; Yuan J
    Am J Nephrol; 2024; 55(3):345-360. PubMed ID: 38330925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin Improves the Renal Autophagy in Rat Experimental Membranous Nephropathy via Regulating the PI3K/AKT/mTOR and Nrf2/HO-1 Signaling Pathways.
    Di Tu Q; Jin J; Hu X; Ren Y; Zhao L; He Q
    Biomed Res Int; 2020; 2020():7069052. PubMed ID: 33204708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement C3a and C3a Receptor Activation Mediates Podocyte Injuries in the Mechanism of Primary Membranous Nephropathy.
    Gao S; Cui Z; Zhao MH
    J Am Soc Nephrol; 2022 Sep; 33(9):1742-1756. PubMed ID: 35777783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyposialylated angiopoietin-like-4 induces apoptosis of podocytes via β1 Integrin/FAK signaling in diabetic nephropathy.
    Guo K; Pan P; Wu M; Ma Y; Lu J; Chen H
    Mol Cell Endocrinol; 2020 Apr; 505():110730. PubMed ID: 31981598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanocortin 1 receptor agonists reduce proteinuria.
    Lindskog A; Ebefors K; Johansson ME; Stefánsson B; Granqvist A; Arnadottir M; Berg AL; Nyström J; Haraldsson B
    J Am Soc Nephrol; 2010 Aug; 21(8):1290-8. PubMed ID: 20507942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.